Aquestive Therapeutics, Inc. Common Stock
Symbol: AQST (NASDAQ)
5.95
▲ (13.04%) 0.686
Company Description:
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Key Stats
- Today's Open: $5.89
- Today's High: $6.416
- Today's Low: $5.56
- Today's Volume: 12.11M
- Yesterday Close: $5.26
- Yesterday High: $5.51
- Yesterday Low: $5.195
- Yesterday Volume: 3.61M
- Last Min Volume: 0
- Last Min High: $5.947
- Last Min Low: $5.946
- Last Min VWAP: $0
Company Profile
- Name: Aquestive Therapeutics, Inc. Common Stock
- Website: https://www.aquestive.com
- Listed Date: 2018-07-25
- Location: WARREN, NJ
- Market Status: Active
- CIK Number: 0001398733
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $636.32M
- Round Lot: 100
- Outstanding Shares: 120.97M
- Asset Type: CS
RECENT FILINGS FOR AQST
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | 4 | View |
| 2025-09-19 | 144 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 8-K | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 144 | View |
| 2025-09-04 | 8-K | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 8-K | View |
| 2025-08-14 | 424B5 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-12 | 4 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
Latest News on AQST